Literature DB >> 8071520

Colonic findings in cirrhotics with portal hypertension. A prospective colonoscopic and histological study.

N Scandalis1, A Archimandritis, K Kastanas, C Spiliadis, B Delis, Z Manika.   

Abstract

Total colonoscopy was performed in 38 consecutive cirrhotics (15 alcoholic, 19 postviral, four unknown) with portal hypertension, 32 of whom were enrolled in a program of esophageal sclerotherapy because of variceal bleeding (Child's grading: A, 13; B, 21; C, 4 patients). In 34 of them, multiple biopsies from the colonic mucosa were taken. Fifty non-cirrhotics (roughly matched for age and sex with the patients) who were colonoscoped because of atypical abdominal complaints, served as controls for rectal varices, polyps, and hemorrhoids. Rectal varices occurred in 3 of 38 (7.9%) of cirrhotics with portal hypertension; they were found only in those who had undergone esophageal sclerotherapy, but no association with the number of sclerotherapies was documented; severity and etiology of cirrhosis did not seem to influence their presence. Hemorrhoids and polyps did not seem to occur more frequently in cirrhotics than in controls. Nonspecific inflammatory changes were observed macroscopically in 57.9% of the patients; these were significantly more common in postviral cirrhosis in comparison with alcoholic cirrhosis (p = 0.01967; 95% CI, 0.757-0.155) and, in particular, in the Child's B postviral cirrhosis as compared with the Child's B alcoholic cirrhosis (p = 0.01915; 90% CI, 0.942-0.320). In 15 patients, there was histological evidence of chronic or acute nonspecific inflammation; no associations with the severity or the etiology of the cirrhosis were found. No vascular ectasias or ectasia-like lesions were found.

Entities:  

Mesh:

Year:  1994        PMID: 8071520     DOI: 10.1097/00004836-199406000-00014

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  8 in total

1.  The risk of postpolypectomy bleeding during colonoscopy in patients with early liver cirrhosis.

Authors:  Jung Won Jeon; Hyun Phil Shin; Joung Il Lee; Kwang Ro Joo; Kwan Mi Pack; Jae Myung Cha; Jae Jun Park; Jun Uk Lim; Kyuseong Lim
Journal:  Surg Endosc       Date:  2012-05-31       Impact factor: 4.584

2.  Increased prevalence of intestinal inflammation in patients with liver cirrhosis.

Authors:  Osamu Saitoh; Kazunori Sugi; Keishi Lojima; Hisashi Matsumoto; Ken Nakagawa; Masanobu Kayazawa; Seigou Tanaka; Tsutomu Teranishi; Ichiro Hirata
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

3.  Hemodynamic evaluation of rectal varices by color Doppler ultrasonography: a case report.

Authors:  Masayuki Nakanowatari; Takahiro Sato; Katsu Yamazaki; Jun Akaike; Tomohiro Arakawa; Yasuaki Kuwata; Takumi Ohmura; Yoshiyasu Karino; Jouji Toyota; Toshihiro Suga
Journal:  J Med Ultrason (2001)       Date:  2007-03-15       Impact factor: 1.314

4.  Portal hypertensive colopathy in patients with liver cirrhosis.

Authors:  Keiichi Ito; Katsuya Shiraki; Takahisa Sakai; Hitoshi Yoshimura; Takeshi Nakano
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

5.  Spontaneous bleeding or thrombosis in cirrhosis: What should be feared the most?

Authors:  Kryssia Isabel Rodríguez-Castro; Alessandro Antonello; Alberto Ferrarese
Journal:  World J Hepatol       Date:  2015-07-18

6.  Use of activated recombinant human factor VII (rhFVIIa) for colonic polypectomies in patients with cirrhosis and coagulopathy.

Authors:  Abhinandana Anantharaju; Kapil Mehta; Ayse L Mindikoglu; David H Van Thiel
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

7.  Cecal varices presenting as anemia: case report and review of the literature.

Authors:  Monica El-Masry; Richard Hu
Journal:  Case Rep Gastroenterol       Date:  2010-12-04

8.  Child-Pugh score is an independent risk factor for immediate bleeding after colonoscopic polypectomy in liver cirrhosis.

Authors:  Sangheun Lee; Soo Jung Park; Jae Hee Cheon; Tae Il Kim; Won Ho Kim; Dae Ryong Kang; Sung Pil Hong
Journal:  Yonsei Med J       Date:  2014-09       Impact factor: 2.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.